Glaucoma Xpress | Expert Videos

1:54

Introduction to Glaucoma Learning Program

Dr. Hutnik introduces the glaucoma learning program, providing a brief overview of the objectives, topics and themes discussed throughout the different video vignettes.

5:36

Glaucoma Overview

Dr. Hutnik highlights the importance of understanding the pathophysiology, epidemiology, and subtypes of glaucoma. She further discusses the progressive nature of glaucoma and decline in glaucoma-related blindness.

11:22

Challenges of Glaucoma Management - the Diagnosis and the Management for Progression

Dr. Hutnik outlines how recent medical advancements have enhanced the diagnosis and management of glaucoma progression and further addresses how promising these developments are for home-based measurements.

14:33

Aiming for Lower Target Pressures with Monotherapy, Combination Therapy &/or Other Emerging Procedures

Dr. Hutnik outlines the role of monotherapy, combination therapy, surgical therapy, and other emerging procedures in decreasing IOP, increasing compliance and decreasing the rate of progression in glaucoma patients.

6:49

Managing Increasing IOP, Following Treatment with Ocular Surgery

Dr. Hutnik outlines the importance of aqueous suppressants, cycloplegic agents and/or corticosteroids in the management of increased IOP, post-ocular surgery.

2:40

The Importance of a Team-Based Model of Care for the Management of Glaucoma

Dr. Hutnik highlights the importance of ophthalmologists and optometrists co-managing glaucoma patients through the London and District Interprofessional Team-Based Model of Care.

2:55

The Pathophysiology of Glaucoma and its Role in Visual Field Loss

Dr. Paul Harasymowycz provides an overview of glaucomatous optic neuropathy leading to visual field loss. He further highlights the importance of early diagnosis and the epidemiology of glaucoma-related blindness in Canada.

6:06

Glaucoma Treatment Algorithm and the Impact of Staging on Target IOP

Dr. Paul Harasymowycz discusses the impact of glaucoma classification, staging and progression rate on the aggressiveness of treatment required to reach target IOP levels. Additionally, he provides a brief overview of the glaucoma treatment algorithm including medical and surgical management.

1:31

Use of Topical Agents in the Management of Increased IOP, Post-Operatively

Dr. Paul Harasymowycz highlights the use of specific topical agents in addition to steroids, in the management of increased IOP, following ocular surgery.

5:02

The Importance of Ophthalmologists and Optometrists Co-Managing Glaucoma Patients

Dr. Paul Harasymowycz emphasizes the importance of collaboration between ophthalmologists and optometrists in the management of glaucoma. He further highlights the use of a colour-based system in the categorization of glaucoma patients to help facilitate the co-management process.

Expert videos, keeping ophthalmologists up-to-date on the latest advancements in Glaucoma management